BridgeMD
Compares treatment options for Peripheral Venous Catheterization
Official title Comparison of the Effectiveness of Ultrasound-guided Techniques and Infrared Illumination, Compared With the Standard Approach to Peripheral Venous Line Placement in People With Difficult Venous Access
ClinicalTrials.gov ID: NCT06838364
What this study is testing
- What it's testing
- Introduction Peripheral venous catheterization (PVC) is the most common invasive procedure in healthcare worldwide. Improving the success rate of PVC on the first attempt is crucial for patients, as it impacts pain, anxiety, the risk of extravasation, rapid access to care, and the patient-provider relationship.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged 18 or over
- Patient with a CT scan appointment and a medical prescription requiring a peripheral venous line.
- Patient with an A-DIVA score greater than or equal to 2.
- Patient able and willing to comply with all study procedures.
- Patient covered by a social security scheme or covered through a third party.
You likely can't join if
- Patient with a contraindication to VVP insertion:
- Arm with arteriovenous fistula
- Limb with an orthopaedic or vascular prosthesis
- Previous mastectomy, axillary lymph node dissection or homolateral radiotherapy of the arm
- Paralysed limb
- Presence of haematomas or puncture site wounds
See the full eligibility criteria
- Patients aged 18 or over
- Patient with a CT scan appointment and a medical prescription requiring a peripheral venous line.
- Patient with an A-DIVA score greater than or equal to 2.
- Patient able and willing to comply with all study procedures.
- Patient covered by a social security scheme or covered through a third party.
- Patients who have given their free and informed written consent following clear and fair information about the study.
- Patient with a contraindication to VVP insertion:
- Arm with arteriovenous fistula
- Limb with an orthopaedic or vascular prosthesis
- Previous mastectomy, axillary lymph node dissection or homolateral radiotherapy of the arm
- Paralysed limb
- Presence of haematomas or puncture site wounds
- Limb with phlebitis or infection
- Patients already included in the study
- Persons benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, pregnant or breast-feeding...
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.